Form 4 for KTTA Pasithea Therapeutics Corp.
Accepted 2022-10-17 00:00:00 ET · period of report 2022-10-17 · accession 0001213900-22-064401 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-17 | 2022-10-17 | KTTA | STEINMAN LAWRENCE | Dir | A - Grant | $1.13 | +10.0K | 1.27M | +0.8% | +$11.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-17 | A | A | 1,000 | $1.14 | 1,263,174 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-17 | A | A | 9,000 | $1.13 | 1,272,174 | D | — | — |